1-4 of 4
Melissa Wright
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Phase 2 Trial of the Monocyte-Targeted Histone Deacetylase Inhibitor Tefinostat (CHR-2845) in Chronic Myelomonocytic Leukemia (CMML) — the UK Monocle Study

Steven Knapper, DM, Michael Dennis, MD, MRCP, FRCPath, Mark W Drummond, PhDMD, Robert K. Hills, MA, DPhil, MSc, Richard James Dillon, MA, PhD MRCP, FRCPath, Christopher Pocock, MD PhD, Dominic J. Culligan, Paresh Vyas, Daniel Wiseman, MB, ChB, Joanna Zabkiewicz, PhD, Marie Hodges, PhD MSc, Catherine Cargo, MB, FRCPath, Jan Taylor, PhD MSc, BSc, Laura Upton, Melissa Wright, David Bowen, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1818.
https://doi.org/10.1182/blood-2018-99-110356
Published: 2018
Journal Articles

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials

Clinical Trials & Observations
Rosemary E. Gale, Teodora Popa, Melissa Wright, Naeem Khan, Sylvie D. Freeman, Alan K. Burnett, Nigel H. Russell, Robert K. Hills, David C. Linch
Journal: Blood
Blood (2018) 131 (4): 468–471.
https://doi.org/10.1182/blood-2017-08-802157
Published: 2018
Includes: Supplemental data
Journal Articles

Prolonged Exposure to FLT3 Inhibitors Leads to Resistance Via Activation of Parallel Signaling Pathways.

Obdulio Piloto, PhD, Melissa Wright, BS, Patrick Brown, MD, Kyu-Tae Kim, PhD, Mark Levis, MD/PhD, Donald Small, MD/PhD
Journal: Blood
Blood (2006) 108 (11): 1380.
https://doi.org/10.1182/blood.V108.11.1380.1380
Published: 2006
Journal Articles

Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways

Obdulio Piloto, Melissa Wright, Patrick Brown, Kyu-Tae Kim, Mark Levis, Donald Small
Journal: Blood
Blood (2006) 109 (4): 1643–1652.
https://doi.org/10.1182/blood-2006-05-023804
Published: 2006
Includes: Supplemental data